Review





Similar Products

93
R&D Systems tumor necrosis factor α
Tumor Necrosis Factor α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor necrosis factor α/product/R&D Systems
Average 93 stars, based on 1 article reviews
tumor necrosis factor α - by Bioz Stars, 2025-05
93/100 stars
  Buy from Supplier

86
Centocor Inc chimeric human mouse monoclonal anti tumor necrosis factor alpha antibody
Chimeric Human Mouse Monoclonal Anti Tumor Necrosis Factor Alpha Antibody, supplied by Centocor Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chimeric human mouse monoclonal anti tumor necrosis factor alpha antibody/product/Centocor Inc
Average 86 stars, based on 1 article reviews
chimeric human mouse monoclonal anti tumor necrosis factor alpha antibody - by Bioz Stars, 2025-05
86/100 stars
  Buy from Supplier

96
Proteintech tumor necrosis factor α tnf α antibody
Tumor Necrosis Factor α Tnf α Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor necrosis factor α tnf α antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
tumor necrosis factor α tnf α antibody - by Bioz Stars, 2025-05
96/100 stars
  Buy from Supplier

86
Revvity anti human tumor necrosis factor alpha tnf α
Anti Human Tumor Necrosis Factor Alpha Tnf α, supplied by Revvity, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human tumor necrosis factor alpha tnf α/product/Revvity
Average 86 stars, based on 1 article reviews
anti human tumor necrosis factor alpha tnf α - by Bioz Stars, 2025-05
86/100 stars
  Buy from Supplier

96
Proteintech tumor necrosis factor α tnf α
Tumor Necrosis Factor α Tnf α, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor necrosis factor α tnf α/product/Proteintech
Average 96 stars, based on 1 article reviews
tumor necrosis factor α tnf α - by Bioz Stars, 2025-05
96/100 stars
  Buy from Supplier

93
R&D Systems human tumor necrosis factor α tnf α monoclonal antibody
Human Tumor Necrosis Factor α Tnf α Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tumor necrosis factor α tnf α monoclonal antibody/product/R&D Systems
Average 93 stars, based on 1 article reviews
human tumor necrosis factor α tnf α monoclonal antibody - by Bioz Stars, 2025-05
93/100 stars
  Buy from Supplier

96
Proteintech tumor necrosis factor tnf
Immunohistochemical staining of the inflammatory factors <t>TNF‐α</t> and IL‐1β in diabetic wounds. (a) Immunohistochemical staining of TNF‐α in diabetic wounds under different treatments. (b) Immunohistochemical staining of IL‐1β of diabetic wounds under different treatments. (c) Statistical analysis of the percentage of TNF‐α‐ and IL‐1β‐positive area in wound tissue ( n = 4). The data are expressed as mean ± SD. * p < 0.05, ** p < 0.01, n.s., no significance (one‐way ANOVA). <t>IL,</t> <t>interleukin;</t> TNF, tumor necrosis factor.
Tumor Necrosis Factor Tnf, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor necrosis factor tnf/product/Proteintech
Average 96 stars, based on 1 article reviews
tumor necrosis factor tnf - by Bioz Stars, 2025-05
96/100 stars
  Buy from Supplier

86
Becton Dickinson anti human tumor necrosis factor alpha
Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in type 1 diabetes patients and their comparison with that in healthy controls. The results are expressed as mean ± SEM. <t>IFN‐γ,</t> <t>interferon</t> gamma; IL, interleukin; PP, peptide pool; PP1–4 IFN‐γ, PP‐stimulated CD4 T cells expressing IFN‐γ; PP1–4 TNF‐α, PP‐stimulated CD4 T cells expressing TNF‐α; PP1–4 IL‐17, PP‐stimulated CD4 T cells expressing IL‐17; PP1–4 IL‐10, PP‐stimulated CD4 T cells expressing IL‐10; TNF‐α, tumor necrosis factor <t>alpha</t>
Anti Human Tumor Necrosis Factor Alpha, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human tumor necrosis factor alpha/product/Becton Dickinson
Average 86 stars, based on 1 article reviews
anti human tumor necrosis factor alpha - by Bioz Stars, 2025-05
86/100 stars
  Buy from Supplier

Image Search Results


Immunohistochemical staining of the inflammatory factors TNF‐α and IL‐1β in diabetic wounds. (a) Immunohistochemical staining of TNF‐α in diabetic wounds under different treatments. (b) Immunohistochemical staining of IL‐1β of diabetic wounds under different treatments. (c) Statistical analysis of the percentage of TNF‐α‐ and IL‐1β‐positive area in wound tissue ( n = 4). The data are expressed as mean ± SD. * p < 0.05, ** p < 0.01, n.s., no significance (one‐way ANOVA). IL, interleukin; TNF, tumor necrosis factor.

Journal: Bioengineering & Translational Medicine

Article Title: Self‐assembly of PEG – PPS polymers and LL ‐37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic wound healing

doi: 10.1002/btm2.10619

Figure Lengend Snippet: Immunohistochemical staining of the inflammatory factors TNF‐α and IL‐1β in diabetic wounds. (a) Immunohistochemical staining of TNF‐α in diabetic wounds under different treatments. (b) Immunohistochemical staining of IL‐1β of diabetic wounds under different treatments. (c) Statistical analysis of the percentage of TNF‐α‐ and IL‐1β‐positive area in wound tissue ( n = 4). The data are expressed as mean ± SD. * p < 0.05, ** p < 0.01, n.s., no significance (one‐way ANOVA). IL, interleukin; TNF, tumor necrosis factor.

Article Snippet: After first incubating the tissue sections with primary antibodies (rabbit anti‐mouse CD31 [1:50, ABclonal, Cat# A0378], anti‐interleukin (IL)‐1 beta rabbit pAb [1:800, Servicebio, GB11113‐100], and tumor necrosis factor (TNF) Alpha [1:400, Proteintech, Cat No. 60291‐1‐lg]) at 4°C for 24 h, the sections were incubated with biotin‐labeled secondary antibody and horseradish enzyme‐labeled streptomyces at room temperature for 2 h. The color reaction was performed using diaminobenzidine (DAB) kit.

Techniques: Immunohistochemistry, Staining

Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in type 1 diabetes patients and their comparison with that in healthy controls. The results are expressed as mean ± SEM. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; PP1–4 IFN‐γ, PP‐stimulated CD4 T cells expressing IFN‐γ; PP1–4 TNF‐α, PP‐stimulated CD4 T cells expressing TNF‐α; PP1–4 IL‐17, PP‐stimulated CD4 T cells expressing IL‐17; PP1–4 IL‐10, PP‐stimulated CD4 T cells expressing IL‐10; TNF‐α, tumor necrosis factor alpha

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in type 1 diabetes patients and their comparison with that in healthy controls. The results are expressed as mean ± SEM. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; PP1–4 IFN‐γ, PP‐stimulated CD4 T cells expressing IFN‐γ; PP1–4 TNF‐α, PP‐stimulated CD4 T cells expressing TNF‐α; PP1–4 IL‐17, PP‐stimulated CD4 T cells expressing IL‐17; PP1–4 IL‐10, PP‐stimulated CD4 T cells expressing IL‐10; TNF‐α, tumor necrosis factor alpha

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing

Multiple comparison (one‐way analysis of variance) analysis of stimulation indices of CD4 T cells expressing IFN‐γ (blue), TNF‐α (brown), IL‐17 (green), and IL‐10 (violet) following stimulation with four peptide pools (PP 1–4) in T1D patients (A) and healthy controls (B). The results are expressed as mean ± SEM. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Multiple comparison (one‐way analysis of variance) analysis of stimulation indices of CD4 T cells expressing IFN‐γ (blue), TNF‐α (brown), IL‐17 (green), and IL‐10 (violet) following stimulation with four peptide pools (PP 1–4) in T1D patients (A) and healthy controls (B). The results are expressed as mean ± SEM. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing

Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 cytokines in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1‐DQB1*02 positive vs negative patients. The results are expressed as mean ± SEM. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 cytokines in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1‐DQB1*02 positive vs negative patients. The results are expressed as mean ± SEM. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing

Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 cytokines in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 cytokines in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing

Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 cytokines in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D patients and HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; SEM, standard error of mean; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Stimulation indices of CD4 T cells expressing IFN‐γ, TNF‐α, IL‐17, and IL‐10 cytokines in response to stimulation with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D patients and HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; SEM, standard error of mean; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing

Ratios of stimulation indices for IFN‐γ/IL‐10 when CD4 T cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative T1D patients, HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative healthy controls and HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D vs HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; SEM, standard error of mean; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Ratios of stimulation indices for IFN‐γ/IL‐10 when CD4 T cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative T1D patients, HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative healthy controls and HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D vs HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; SEM, standard error of mean; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques:

Ratios of stimulation indices for IL‐17/IL‐10 when the CD4 T cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative T1D patients, HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative healthy controls and HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D vs HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; SEM, standard error of mean; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Ratios of stimulation indices for IL‐17/IL‐10 when the CD4 T cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative T1D patients, HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive vs negative healthy controls and HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D vs HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive healthy controls. The results are expressed as mean ± SEM. HC, healthy controls; IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; SEM, standard error of mean; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques:

Stimulation indices of CD4 T cells' expression of IFN‐γ, TNF‐α, IL‐17, and IL‐10 when the cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in recently diagnosed and long‐standing T1D patients. The results are represented by box and whisker plots where boxes represent mean ± SEM and whiskers represent 10–90 percentile data range. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Stimulation indices of CD4 T cells' expression of IFN‐γ, TNF‐α, IL‐17, and IL‐10 when the cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in recently diagnosed and long‐standing T1D patients. The results are represented by box and whisker plots where boxes represent mean ± SEM and whiskers represent 10–90 percentile data range. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing, Whisker Assay

Stimulation indices of CD4 T cells' expression of IFN‐γ, TNF‐α, IL‐17, and IL‐10 when the cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in recently diagnosed and long‐standing HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D patients. The results are represented by box and whisker plots where boxes represent mean ± SEM and whiskers represent 10–90 percentile data range. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Journal: Journal of Diabetes

Article Title: HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

doi: 10.1111/1753-0407.13406

Figure Lengend Snippet: Stimulation indices of CD4 T cells' expression of IFN‐γ, TNF‐α, IL‐17, and IL‐10 when the cells were stimulated with four different GAD65 peptide pools (PP1, PP2, PP3, and PP4) in recently diagnosed and long‐standing HLA‐DRB1*03‐DQA1*05‐DQB1*02 positive T1D patients. The results are represented by box and whisker plots where boxes represent mean ± SEM and whiskers represent 10–90 percentile data range. IFN‐γ, interferon gamma; IL, interleukin; PP, peptide pool; T1D, type 1 diabetes; TNF‐α, tumor necrosis factor alpha.

Article Snippet: The intracellular cytokine staining was performed on permeabilized and fixed cells with BV480 mouse anti‐human interferon‐gamma (IFN‐γ; 566100, BD Biosciences, USA), APC mouse anti‐human tumor necrosis factor‐alpha (TNF‐α; 554514, BD Biosciences, USA), PE mouse anti‐human IL‐17A (560486, BD Biosciences, USA), and BV421 rat anti‐human and viral IL‐10 (564053, BD Biosciences, USA) antibodies.

Techniques: Expressing, Whisker Assay